Scientists have recently made promising headway toward discovering new antibiotics. In July, researchers announced a new antibiotic called lugdunin that is produced by bacteria in the human nose. And last year, scientists discovered the chemical teixobactin in microbes grown in soil. Both have the power to fight many antibiotic-resistant bacteria, including S. aureus. They are the first new classes of antibiotics found in almost 30 years.
Some scientists think more needs to be done to motivate pharmaceutical companies to invest in developing new antibiotics. Ezekiel Emanuel, who heads the Department of Medical Ethics and Health Policy at the University of Pennsylvania, suggests awarding a cash prize to the creators of new antibiotics. He says the money could come from a small tax on hospitals: If 2 cents were set aside from every $10 paid to U.S. hospitals, it would generate $2 billion a year. It could be money well spent—if the medicines kept people healthy and out of hospitals.
Although the rise in superbugs is troubling, Fortune says you shouldn’t panic about catching one of these bacteria. “The vast majority of people go through their whole lives without getting an antibiotic-resistant infection,” she says. “But for people who are impacted, scientists are working hard to make new medicines to treat them.”